Wyeth Ayerst
A double-blind comparative study of the effect of two dose levels of Sirolimus versus azathioprine, administered concomitantly with standard immuno--suppressive therapy in renal allograft recipients
Principal Investigator: Patricia Adams, M.D. | 1996-1999 |
Sangstat
Controlled, randomized open label multi-center study comparing Sang-35 oral solution with Neoral capsules in de novo adult renal allograft recipients.
Principal Investigator: Patricia Adams, M.D. | 1998-2000 |
National Institutes of Health
“Family Investigation in Nephropathy and Diabetes (FIND)"
Principal Investigator: Barry I. Freedman, M.D.
Co-Investigator: Scott G. Satko, M.D. | 1999-2006 |
National Institutes of Health,(Subcontract with University of Pittsburgh)
"Genotype and Phenotype of Familial Nephropathy with Gout"
Principal Investigator:Thomas Hart, M.D. (University of Pittsburgh)
Principal Investigator: Anthony J. Bleyer, M.D. | 2002-2006 |
Genzyme Pharmaceuticals
"A Randomized, Open Label, Parallel Design Study of Sevelamer Hydrochloride (Renagel) in Chronic Kidney Disease Patients"
Principal Investigator: Anthony J. Bleyer, M.D. | 2002-present |
National Institutes of Health
PAS (Subcontract with Case Western Reserve University)
"Renal Disease Progression in African Americans"
Principal Investigator: Jeffrey Schelling, M.D. (Case Western Reserve University)
Principal Investigator: Anthony J. Bleyer, M.D.
Co‑Investigator: Barry I. Freedman, M.D.
Co-Investigator: John M. Burkart, M.D. | 2002-2008 |
National Institutes of Health
“Genetics of African American Type 2 Diabetes”
Principal Investigator: Michele Sale, Ph.D.
Co-Investigator: Barry I. Freedman, M.D. | 2003-2007 |
National Institutes of Health/VA
"Intensive versus Conventional Renal Support in Acute Renal Failure"
Principal Investigator: Michael V. Rocco, M.D. | 2003-2007 |
Southeastern Kidney Council, Inc.
“Family History of ESRD Prevention Project”
Principal Investigator: Scott Satko, M.D.
Co-Investigator: Barry I. Freedman, M.D. | 2003-present |
National Institutes of Health
"Frequent Hemodialysis Clinical Trial" (Nocturnal HD)
Principal Investigator for the nocturnal clinical coordinating center: Michael V. Rocco, M.D.
Co-Investigator: John M. Burkart, M.D. | 2003-2009 |
National Institutes of Health
"Dialysis Access Consortium” - Clinical center
Principal Investigator: Michael V. Rocco, M.D.
Co-investigator: Pirouz Daeihagh, M.D. | 2004-2007 |
National Institutes of Health
"Identification of Diabetes Genes on Human Chromosome 20"
Principal Investigator: Donald Bowden, Ph.D.
Co‑Investigator: Barry I. Freedman, M.D. | 2005-2010 |
National Institutes of Health
“Subclinical CVD in African American type 2 diabetes”
Principal Investigator: Barry Freedman, M.D. | 2005-2010 |
Keryx Biopharmaceuticals Inc.
The effect of sulodexide in patients with type 2 diabetes and microalbuminuria
Co-investigator: Pirouz Daeihagh, M.D | 2006 |
Isotechnika Research
“A Phase IIB, randomized, multicenter, open-label, concentration-controlled, safety study of ISA247 and tacrolimus in de novo renal transplant patients” (PROMISE Trial: Protocol ISA05-01)
Site Principal Investigator: Erica Hartmann, M.D. | 2006-present |
Rhubarb and Angiotensin Converting Enzyme Inhibitor Study (RACE) II
Principal Investigator: John Burkhard, M.D. | 2006-present |
Roche Research
“A Randomized, Double-Blind, Placebo Controlled Multi-Center Study of the Efficacy and Safety of up to 100 days of Valganciclovir versus up to 200 days of Valganciclovir for Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients” (IMPACT Trial: Protocol NT18435)
Site Principal Investigator: Erica Hartmann, M.D. | 2006-present |
Treatment Resistant Heart Failure and Peritoneal Ultrafiltration
Principal Investigator: John Burkhart, M.D. | 2006-present |
American Society of Nephrology and Association of Subspecialty Professors
Junior Development Grant in Geriatric Nephrology
Principal Investigator: Erica Hartmann, M.D. | 2006-2008 |
National Institutes of Health
“Genetic Analysis of African American Hypertensive End-Stage Renal Disease”
Principal Investigator: Barry I. Freedman, M.D. | 2006-2010 |
Role of blood pressure changes on residual renal function in patients on automated peritoneal dialysis.
Principal Investigator: Pirouz Daeihagh, M.D. | 2007- present |